thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930, BCX9250, peramivir, galidesivir, and early stage discovery programs

EX-10.87 12 ex_230497.htm EXHIBIT 10.87 ex_230497.htm

Exhibit 10.87